Bis zu 50 % günstiger als neu 3 Jahre rebuy Garantie Professionelles Refurbishment
ElektronikMedien
Tipps & News
AppleAlle anzeigen
TabletsAlle anzeigen
HandyAlle anzeigen
Fairphone
AppleAlle anzeigen
iPhone Air Generation
GoogleAlle anzeigen
Pixel Fold
HonorAlle anzeigen
HuaweiAlle anzeigen
Honor SerieY-Serie
NothingAlle anzeigen
OnePlusAlle anzeigen
OnePlus 11 GenerationOnePlus 12 Generation
SamsungAlle anzeigen
Galaxy XcoverWeitere Modelle
SonyAlle anzeigen
Weitere Modelle
XiaomiAlle anzeigen
Weitere Modelle
Tablets & eBook ReaderAlle anzeigen
Google
AppleAlle anzeigen
HuaweiAlle anzeigen
MatePad Pro Serie
MicrosoftAlle anzeigen
XiaomiAlle anzeigen
Kameras & ZubehörAlle anzeigen
ObjektiveAlle anzeigen
System & SpiegelreflexAlle anzeigen
WearablesAlle anzeigen
Fitness TrackerAlle anzeigen
SmartwatchesAlle anzeigen
Xiaomi
Konsolen & ZubehörAlle anzeigen
Lenovo Legion GoMSI Claw
NintendoAlle anzeigen
Nintendo Switch Lite
PlayStationAlle anzeigen
XboxAlle anzeigen
Audio & HiFiAlle anzeigen
KopfhörerAlle anzeigen
FairphoneGoogle
LautsprecherAlle anzeigen
Beats by Dr. DreGoogleYamahatonies
iPodAlle anzeigen

Handgeprüfte Gebrauchtware

Bis zu 50 % günstiger als neu

Der Umwelt zuliebe

The Biology of Dendritic Cells and HIV Infection

(Gebundene Ausgabe, Englisch)

Keine Bewertungen vorhanden
Optischer Zustand
Beschreibung
Dendritic cells play the most vital part in inducing anti-viral immune responses in HIV and AIDS among many other viruses. Research on dendritic cells (DCs) is emerging as a fundamental aspect for the comprehension of the mechanisms underlying the pathogenesis of viral diseases as well as for the progress on the development of prophylactic and therapeutic vaccines. This volume focuses on the role of DCs in the pathogenesis and immunity of HIV-1 infection. It has recently been clarified that DCs are important targets and reservoirs of HIV and may play an important role in virus spreading to T cells. Interestingly, HIV can exploit many of the cellular processes responsible for the generation and regulation of the adaptive immune responses to gain access to its main target cells, i.e. the CD4 + T lymphocytes. Thus, the central role of DCs in stimulating T cell activation not only provides a route for viral transmission, but also represents a vulnerable point at which HIV-1 can interfere with the initiation of primary T cell immunity. Recent studies have revealed that several HIV proteins can profoundly influence the phenotype and functions of DCs even in the absence of a productive infection, often resulting in an abnormal immune response. While this knowledge has resulted in the identification of some major mechanisms involved in the pathogenesis of HIV-1 infection, the recent progress on DC biology has opened perspectives in the research on new adjuvants (selectively acting on DCs) and on novel strategies for the in vivo targeting of antigens to DCs, which appear to be highly relevant for the development of HIV vaccines. Of note, defects in the number and functions of DCs have been observed in the course of HIV infection and during disease progression, thus suggesting that DCs play an important role in the immune control of viral replication and virus-induced dysfunctions. The development of therapeutic vaccination strategies to be combined with HAART is thought as an important step for an effective control of HIV infection in patients. In this context, the use of autologous DCs may represent an attracting strategy. Notably, DCs are now regarded as a valuable approach for the development of cancer vaccines and several clinical trials have explored the efficacy of different DC preparations as cellular adjuvants in inducing a potentially protective immune response. Recent data in animal models provide the background for the clinical testing of DC-based vaccines in HIV-1-infected patients. Now that we start to understand the complex interactions between HIV and DCs in the pathogenesis of AIDS and we are learning how to prepare potentially effective DCs from lessons on cancer vaccines, we may reasonably assume that DC-based therapeutic vaccines can represent a topic of increasing interest in protocols of clinical immunotherapy of HIV-1-infected patients.
Dieses Produkt haben wir gerade leider nicht auf Lager.
ab 47,99 €
Derzeit nicht verfügbar
Derzeit nicht verfügbar

Handgeprüfte Gebrauchtware

Bis zu 50 % günstiger als neu

Der Umwelt zuliebe

Technische Daten


Erscheinungsdatum
07.02.2007
Sprache
Englisch
EAN
9780387337845
Herausgeber
Springer US
Sonderedition
Nein
Seitenanzahl
544
Auflage
1
Einbandart
Gebundene Ausgabe
Schlagwörter
AIDS, Antigen, HIV, HIV infection, Regulation, Virus, Viruses, cell biology, cellular processes, infection, infections, influence, proteins, vaccine, viral infection, infectious diseases
Thema-Inhalt
PSF - Zellbiologie (Zytologie) MJCM - Immunologie MJC - Krankheiten und Störungen MKF - Pathologie PSG - Mikrobiologie (nicht-medizinisch)
Höhe
235 mm
Breite
15.5 cm

Hersteller: Humana, Europaplatz 3, Heidelberg, Deutschland, 69115, ProductSafety@springernature.com, Springer Nature Customer Service Center GmbH

Warnhinweise und Sicherheitsinformationen

Informationen nach EU Data Act

-.-
Leider noch keine Bewertungen
Leider noch keine Bewertungen
Schreib die erste Bewertung für dieses Produkt!
Wenn du eine Bewertung für dieses Produkt schreibst, hilfst du allen Kund:innen, die noch überlegen, ob sie das Produkt kaufen wollen. Vielen Dank, dass du mitmachst!